FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Mallinckrodt Hospital Products Terlivaz Recall

Terlivaz (terlipressin for injection), 0

Mallinckrodt Hospital Products Inc. · Bridgewater, NJ

Risk level
Class II
Reported by FDA
Feb 28, 2024
Recall ID
D-0341-2024
Check your lot numberHow we source this data

Summary

Mallinckrodt Hospital Products recalled Terlivaz starting Feb 6, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0341-2024 on Feb 28, 2024. Reason: cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified. Status: Ongoing.

Why it was recalled

cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.

Product description

Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Hospital Products Inc., Bridgewater, NJ 08807, USA, NDC 43825-200-01

Lot numbers, UPCs & expiration codes

Lot #: 22TRP01-F2, Exp 6/30/2024

Where it was sold

USA nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0341-2024
Classification
Class II
Status
Ongoing
Recall initiated
Feb 6, 2024
FDA report date
Feb 28, 2024
Quantity
421 vials involved in this recall (2,448 vials distributed)
Recall type
Voluntary: Firm initiated
Recalling firm
Mallinckrodt Hospital Products Inc.

Original FDA data

Every field from FDA enforcement report D-0341-2024, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Ongoing
Country
United States
Event ID
93945
Address
440 Us Highway 22
Address (line 2)
Ste 302
Code information
Lot #: 22TRP01-F2, Exp 6/30/2024
Postal code
08807-2477
Report date
Feb 28, 2024
Product type
Drugs
Recall number
D-0341-2024
Classification
Class II
Recalling firm
Mallinckrodt Hospital Products Inc.
Product quantity
421 vials involved in this recall (2,448 vials distributed)
Reason for recall
cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Hospital Products Inc., Bridgewater, NJ 08807, USA, NDC 43825-200-01
Distribution pattern
USA nationwide
Recall initiation date
Feb 6, 2024
Initial firm notification
Letter
Center classification date
Feb 21, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0341-2024, published Feb 28, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls